Skip to main content
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.420
-0.030 (-2.07%)
At close: Apr 28, 2026, 4:00 PM EDT
1.490
+0.070 (4.93%)
After-hours: Apr 28, 2026, 5:57 PM EDT

Marker Therapeutics Revenue

In the year 2025, Marker Therapeutics had annual revenue of $3.55M, down -46.19%. Marker Therapeutics had revenue of $1.10M in the quarter ending December 31, 2025, a decrease of -51.00%.

Revenue (ttm)
$3.55M
Revenue Growth
-46.19%
P/S Ratio
6.68
Revenue / Employee
$709,334
Employees
5
Market Cap
23.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.55M-3.04M-46.19%
Dec 31, 20246.59M3.28M99.06%
Dec 31, 20233.31M-202.41K-5.76%
Dec 31, 20223.51M2.27M182.96%
Dec 31, 20211.24M774.93K166.01%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Curis 9.44M
OSR Holdings 2.91M
Vistagen Therapeutics 789.00K
VYNE Therapeutics 570.00K
Exicure 500.00K
Lexaria Bioscience 368.00K
Serina Therapeutics 130.00K
Revenue Rankings

MRKR News

More News